Match!

Key principles for the improved conduct of health technology assessments for resource allocation decisions

Published on Jul 1, 2008in International Journal of Technology Assessment in Health Care1.418
· DOI :10.1017/S0266462308080343
Michael Drummond72
Estimated H-index: 72
(Ebor: University of York),
J. Sanford Schwartz61
Estimated H-index: 61
(UPenn: University of Pennsylvania)
+ 4 AuthorsSean D. Sullivan65
Estimated H-index: 65
(UW: University of Washington)
Abstract
Health technology assessment (HTA) is a dynamic, rapidly evolving process, embracingdifferent types of assessments that inform real-world decisions about the value (i.e.,benefits, risks, and costs) of new and existing technologies. Historically, most HTAagencies have focused on producing high quality assessment reports that can be used bya range of decision makers. However, increasingly organizations are undertaking orcommissioning HTAs to inform a particular resource allocation decision, such as listing adrug on a national or local formulary, defining the range of coverage under insuranceplans, or issuing mandatory guidance on the use of health technologies in a particularhealthcare system. A set of fifteen principles that can be used in assessing existing orestablishing new HTA activities is proposed, providing examples from existing HTAprograms. The principal focus is on those HTA activities that are linked to, or include, aparticular resource allocation decision. In these HTAs, the consideration of both costs andbenefits, in an economic evaluation, is critical. It is also important to consider the linkbetween the HTA and the decision that will follow. The principles are organized into foursections: (i) “Structure” of HTA programs; (ii) “Methods” of HTA; (iii) “Processes forConduct” of HTA; and (iv) “Use of HTAs in Decision Making.”
  • References (33)
  • Citations (257)
📖 Papers frequently viewed together
1987
9,698 Citations
1996
3,434 Citations
168 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References33
Newest
#1Ezekiel J. EmanuelH-Index: 81
#2Victor R. FuchsH-Index: 44
Last. Alan M. GarberH-Index: 63
view all 3 authors...
THE MISMATCH BETWEEN US HEALTH EXPENDITURES AND the resources devoted to learning which health interventions are most effective is both striking and unwise. Each year US individuals spend more than 2 trillion on health care. More than 00 billion is spent for research and development and for regulatory approval of new technologies. Yet total spending on technology assessment almost certainly falls short of 1 billion per year— 0.05% of all US health care spending. Some of the trillion in he...
66 CitationsSource
#1Louis P. Garrison (UW: University of Washington)H-Index: 29
#2Peter J. Neumann (Tufts Medical Center)H-Index: 81
Last. C. Daniel Mullins (UMB: University of Maryland, Baltimore)H-Index: 30
view all 5 authors...
Abstract Objective Health decision-makers involved with coverage and payment policies are increasingly developing policies that seek information on "real-world" (RW) outcomes. Motivated by these initiatives, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) created a Task Force on Real-World Data to develop a framework to assist health-care decision-makers in dealing with RW data, especially related to coverage and payment decisions. Methods Task Force cochairs were s...
317 CitationsSource
Evidence-based medicine (EBM) has increasingly influenced decision making in health policy and patient care. Appropriate use of EBM in decision making requires a clear understanding of the distinct “anatomical” components of all decisions: (1) scientific evidence and (2) judgments applied to that evidence by individuals or organizations. In this interview, Sean Tunis discusses these principles with David Eddy. Tunis has provided leadership at the national level in applying EBM principles to heal...
53 CitationsSource
#1Hussein Noorani (Canadian Agency for Drugs and Technologies in Health)H-Index: 5
#2Don Husereau (Canadian Agency for Drugs and Technologies in Health)H-Index: 20
Last. Becky SkidmoreH-Index: 22
view all 4 authors...
Objectives: This study sought to identify and compare various practical and current approaches of health technology assessment (HTA) priority setting. Methods: A literature search was performed across PubMed, MEDLINE, EMBASE, BIOSIS, and Cochrane. Given an earlier review conducted by European agencies (EUR-ASSESS project), the search was limited to literature indexed from 1996 onward. We also searched Web sites of HTA agencies as well as HTAi and ISTAHC conference abstracts. Agency representativ...
101 CitationsSource
#2LeighAnne OlsenH-Index: 12
#3Dara L. AisnerH-Index: 37
Last. J. Michael McGinnisH-Index: 22
view all 3 authors...
63 Citations
#1Alan Brennan (University of Sheffield)H-Index: 37
#2Stephen E. Chick (Ad: INSEAD)H-Index: 29
Last. Ruth Davies (Warw.: University of Warwick)H-Index: 21
view all 3 authors...
Models for the economic evaluation of health technologies provide valuable information to decision makers. The choice of model structure is rarely discussed in published studies and can affect the results produced. Many papers describe good modelling practice, but few describe how to choose from the many types of available models. This paper develops a new taxonomy of model structures. The horizontal axis of the taxonomy describes assumptions about the role of expected values, randomness, the he...
275 CitationsSource
#1Peter J. Neumann (Tufts Medical Center)H-Index: 81
#2Sean D. Sullivan (UW: University of Washington)H-Index: 65
In this paper we consider the evolving American healthcare landscape and what it means for the use of economic evaluation of health interventions. We emphasise that use of economic evaluation in the US is unlikely to follow the European, Canadian or Australian models, which use cost effectiveness openly and explicitly, given the decentralised manner in which American healthcare is organised, financed and delivered, as well as different political systems and traditions, and cultural expectations ...
29 CitationsSource
Interest in objective, credible comparative clinical effectiveness information has been growing in the United States, both by those who support competitive behavior in health care and by those who support administered pricing. The Medicare drug benefit has heightened interest in better information, although the potential payoff is even greater for medical procedures than for drugs, since procedures account for more of the health care dollar. Careful consideration needs to be given regarding the ...
138 CitationsSource
#1Mark Sculpher (Ebor: University of York)H-Index: 75
#2Michael Drummond (Ebor: University of York)H-Index: 72
Over the last decade or so, a number of healthcare systems have used economic evaluations as a formal input into decisions about the coverage or reimbursement of new healthcare interventions. This change in the policy landscape has placed some important demands on the design and characteristics of economic evaluation and these are increasingly evident in studies being presented to decision makers. One challenge has been to make studies specific to the context in which the decision is being taken...
55 CitationsSource
#1Ron Goeree (McMaster University)H-Index: 46
#2Leslie Levin (U of T: University of Toronto)H-Index: 1
Healthcare expenditure in Ontario has been escalating at increasing rates and a growing proportion of this has come from medical devices and other technologies.
42 CitationsSource
Cited By257
Newest
#1Hye-Young Kwon (SNU: Seoul National University)H-Index: 6
#2Jinhyun Kim (SNU: Seoul National University)H-Index: 22
Abstract Objectives This study aims to explore the performance of price negotiations, over a period of 10 years, and identify individual variations in pricing that directly affect the consistency of pricing decisions. Methods Existing literature and relative regulations were reviewed, and data provided by the National Health Insurance Service (NHIS) was analysed to evaluate the performance of price negotiations. To examine individual variations in pricing, hypothetical scenarios of four types of...
Source
#1Brian O'Rourke (Canadian Agency for Drugs and Technologies in Health)H-Index: 3
#2Wija Oortwijn (Radboud University Nijmegen)H-Index: 11
Last. Tara SchullerH-Index: 2
view all 3 authors...
Source
Zusammenfassung Hintergrund Entscheidungen zur Kostenubernahme (Erstattungsentscheidungen) sind Entscheidungen von Drittzahlern daruber, ob, in welcher Hohe und unter welchen Bedingungen Kosten fur Technologien oder Dienstleistungen ubernommen werden. Aufgrund der Komplexitat solcher Entscheidungen ist hierbei eine systematische und transparente Herangehensweise erforderlich. Im Rahmen des DECIDE-Projekts (DECIDE: Developing and Evaluating Communication Strategies to Support Informed Decisions a...
Source
BACKGROUND: An international joint task group co-led by the International Network of Agencies for Health Technology Assessment (INAHTA) and Health Technology Assessment International (HTAi) has developed a new and internationally accepted definition of HTA. METHODS: The task group, consisting of representatives of leading HTA networks, societies and global organizations, developed guiding principles for the process and followed an established consultation plan with the broader HTA community to d...
1 CitationsSource
Health technology assessment (HTA) recommendations informed by patient concerns are seen to ensure democracy and legitimacy. We explored how written and oral patient involvement in two HTAs was reported on in publicly available final recommendations and discussion summaries of appraisal committees from three HTA bodies. We aimed to gain insights into how patient input was utilized by appraisal committees to better understand the goals of patient involvement and how these are being achieved. In e...
Source
#1Vanessa L Scarf (UTS: University of Technology, Sydney)H-Index: 4
#2Serena Yu (UTS: University of Technology, Sydney)H-Index: 5
Last. Caroline S.E. Homer (UTS: University of Technology, Sydney)H-Index: 34
view all 7 authors...
Abstract Background Women want greater choice of place of birth in New South Wales, Australia. It is perceived to be more costly to health services for women with a healthy pregnancy to give birth at home or in a birth centre. It is not known how much it costs the health service to provide care for women planning to give birth in these settings. Aim The aim of this study was to determine the direct cost of giving birth vaginally at home, in a birth centre or in a hospital for women at low risk o...
Source
#1Andres Pichon-Riviere (CONICET: National Scientific and Technical Research Council)H-Index: 14
#2Federico Augustovski (CONICET: National Scientific and Technical Research Council)H-Index: 25
Last. Laura Sampietro-ColomH-Index: 14
view all 5 authors...
OBJETIVOS: Un vinculo claro entre la evaluacion y la toma de decision constituye un principio de buena practica en evaluacion de tecnologias sanitarias (ETESA) reconocido a nivel internacional. El objetivo del Foro de Politicas en Latino-America (LatamPF) 2019 de Health Technology Assessment International fue explorar los diferentes modelos que vinculan la ETESA y la toma de decision y discutir su potencial aplicabilidad en Latino-America. METODOS: Este manuscrito esta basado en un documento bas...
Source
#1Andres Pichon-Riviere (CONICET: National Scientific and Technical Research Council)H-Index: 14
#2Federico Augustovski (CONICET: National Scientific and Technical Research Council)H-Index: 25
Last. Laura Sampietro-ColomH-Index: 14
view all 5 authors...
OBJECTIVE: One of the good practice principles for health technology assessment (HTA) is having a clear link between the assessment and decision making. The objective of the 2019 Latin American Policy Forum (LatamPF) of Health Technology Assessment International was to explore different models of connection between HTA and decision making and to discuss the potential applicability of such models in Latin America. METHODS: This paper is based on a background document and the deliberations of the ...
1 CitationsSource
#1Nereo VettorettoH-Index: 21
#2Emanuela FogliaH-Index: 8
Last. Ugo Elmore (UniSR: Vita-Salute San Raffaele University)H-Index: 10
view all 24 authors...
BACKGROUND: Indocyanine green fluorescence vision is an upcoming technology in surgery. It can be used in three ways: angiographic and biliary tree visualization and lymphatic spreading studies. The present paper shows the most outstanding results from an health technology assessment study design, conducted on fluorescence-guided compared with standard vision surgery. METHODS: A health technology assessment approach was implemented to investigate the economic, social, ethical, and organizational...
Source
Although mammography screening significantly reduces breast cancer mortality, women could present different morphological characteristics that do not allow the correct vision of their breasts and t...
Source